Skip to main content
. 2020 Mar 18;179(9):1445–1452. doi: 10.1007/s00431-020-03630-7

Table 1.

Clinical, laboratory, and genetic features in patients with MC4R gene variants (+)

Case number Sex/age (years) Age at onset of obesity (years) Height SDS/BMI SDS Comorbidity HOMA-IR cDNA Protein ACMG/AMP Mutation type MT SIFT GERP ExAC*#(overall allele frequency) Novel
1 M/10 3 1.9/3.7 AN, IR 6.3 c.821 A > G/wt p.N274S/wt P MS DC D 5.8499 0.00001647
2 F/8.6 2 1.9/2.7 IR, hepatosteatosis 4.4 c.496 G > A/wt p.V166I/wt UP MS DC D 5.8499 0.00000879
3 M/8.5 2 3.2/4.6 IR, depression, social isolation 8.1 c.496 G > A/wt p.V166I/wt UP MS DC D 5.8499 0.00000879
4 M/14 1 0.8/3.6 IR, hepatosteatosis, TSH elevation 7.3 c.407 C > T/wt p.S136F/wt UP MS DC D 5.6999
5 M/2 0.6 1.8/7.3 IR 3.2 c.870delG/c.870delG p.I291Sfs*10/ p.I291Sfs*10 LP fs DC NA 6.0599
6 F/8 4 1.2/2.9 AN, IR 3.4 c.821 A > G/wt p.N274S/wt P MS DC D 5.8499 0.0000176
7 F/14 2 1.0/3.1 IR, hepatosteatosis 4.6 c.407 C > T/wt p.S136F/wt US MS DC D 5.6999
8 M/14.5 3 1.1/3.0 IR 6.2 c.821 A > G/wt p.N274S/wt P MS DC D 5.8499 0.00001647
9 M/2.5 0.5 1.8/3.1 None 0.8 c.563C > T p.S188L/wt US MS DC D 5.8499 0.00000879 +
10 M/13.3 3.5 − 1.4/3.2 IR, hepatosteatosis 4.6 c.493C > T p.R165W/wt US MS DC D 5.8499 0.0000176
11 M/11.7 4 0.4/2.9 IR 3.7 c.597_599delCAT p.M200del/wt US del 5.8499 +
12 M/16 5 2.8/3.8 IR/AN/hepatosteatosis/hypertension/TSH elevation 8.1 c.821A > G p.N274S/wt P MS DC T 5.8499 0.0000176

*Exome Aggregation Consortium (http://exac.broadinstitude.org). # The allele frequency in the ExAC database does not contain representative controls for all ethnic groups

M male, F female, MS missense, NS nonsense, del deletion, fs frame shift, MT MutationTaster, DC disease causing, PD probably damaging, D damaging, T tolerated, NA not available, wt wild type, P pathogenic, LP likely pathogenic, US uncertain significance, SIFT sorting intolerant from tolerant, AN acanthosis nigricans, IR insulin resistance